John Riches (@richeslab) profile picture

Clinical Reader and Consultant Haemato-oncologist at Barts Cancer Institute/Barts Hospital Specialist interest in chronic leukaemia and lymphoma

London, England
Joined December 2017
Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)Photo by John Riches (@richeslab)
My recommended paper this week is by Pushkal Sharma, Ankur Jain and team who show that polyamines buffer labile iron, restraining its reactivity to suppress ferroptosis. Polyamine depletion raises labile iron creating synthetic lethality with GPX4 loss. cell.com/cell/fulltext/S0092…
54
Great opportunity for clinicians to do a PhD with the CRUK City of London Clinical Training Programme. I have a project with Prof Alan Ramsay at Kings investigating stromal metabolic vulnerabilities regulating immune infiltration in lymphoma - please contact me if interested.
1
130
This weeks recommended read is from Deborah Suissa, Laurence Zitvogel and team who looked at plasma samples and found that higher histidine was linked to better outcomes, while succinate and long-chain FAs predicted poorer survival with immunotherapy. nature.com/articles/s41591-0…
62
Great news! Acalabrutinib, in combination with Venetoclax, has been approved by NICE for adults in England and Wales with previously untreated CLL.
🚨 BIG NEWS for blood cancer patients in England. NICE has recommended #Acalabrutinib for both #MantleCellLymphoma and #CLL, opening up new first-line treatment options for nearly 800 people. More 👉 nationalhealthexecutive.com/… @NICEComms @AstraZeneca #BloodCancer #Lymphoma #Leukaemia #CancerCare #NHS
1
159
🚨 BIG NEWS for blood cancer patients in England. NICE has recommended #Acalabrutinib for both #MantleCellLymphoma and #CLL, opening up new first-line treatment options for nearly 800 people. More 👉 nationalhealthexecutive.com/… @NICEComms @AstraZeneca #BloodCancer #Lymphoma #Leukaemia #CancerCare #NHS
1
3
2
3
2,308
This weeks recommended paper is by Samuel Witus and Michael Rapé +team who show that purine nucleotides stabilise the PPAT–NUDT5 complex to provide feedback control of purine biosynthesis, while thiopurines exploit the same interface with greater potency: nature.com/articles/s41586-0…
1
1
76
This week's recommended read is by Madeleine Hart and Lucas Sullivan and team who show that SDH inhibition triggers a rebound in aspartate, yet pyrimidine synthesis and proliferation remain blocked because accumulated succinate inhibits ATCase. doi.org/10.1038/s42255-026-0…
42
This week my recommended read is by Ivan Montes, Hesham Sadek and team who show that mitochondria interact with nuclear pores via VDAC1–RANBP2. This contact fuels nuclear energetics, regulates gene expression, and is essential for cell differentiation. nature.com/articles/s41586-0…
104
This week's paper is from Yuheng Liao and Hui Yang and team: aspartate restriction triggers mtDNA stress and cytosolic mtDNA release, amplifying type I IFN responses via a ZBP1-driven loop to boost the efficacy of STING agonists, chemo, and radiotherapy. jci.org/articles/view/199716
51
This week's recommended read is by Lennart Hoffmann, Tanja Maritzen and team who show that aldolase links metabolism to cell adhesion, with FBP acting as a signal to boost Rac1 activity to reorganize actin, enhance adhesion, and drive cell protrusion. nature.com/articles/s41556-0…
1
62
This week's recommended cancer metabolism paper is by Fenfen Ji and Chi Chun Wong and team who show that BCAA metabolism regulates colorectal cancer dissemination through UMP-mediated stabilisation of vimentin. Targeting BCAA metabolism can stop CRC mets. doi.org/10.1016/j.cmet.2026.…
57
⚠ #ESHMM2026 STARTS THIS THURSDAY! Last chance to register, don't miss out, proceed now 👉bit.ly/4cy6PCW March 26-28 in Stockholm, Sweden 8th Translational Research Conference Multiple Myeloma Chairs: Hartmut Goldschmidt, @MyMKaiser, @SLentzsch #ESHCONFERENCES #MMsm
8
8
1,138
This week's paper is by Anna Bång-Rudenstam and Mattias Belting and team who show a chondroitin sulfate–rich glycocalyx in glioblastoma blocks lipid uptake, protects from ferroptosis, and drives survival. Targeting this => lipid peroxidation & cell death. nature.com/articles/s41556-0…
83
This week my recommended cancer metabolism paper is by Savvas Kourtis, Sara Sdelci and team who show that metabolic enzyme "moonlighting" on chromatin is widespread across various tissues and metabolic pathways in a tissue-specific manner. Great work! nature.com/articles/s41467-0…
326
This week's recommended paper is by Naiqi Wang and Di Yu and team who show that dietary PUFAs and MUFAs influence T cell lipid composition and resistance to ferroptosis, to regulate immune responses, with implications for vaccines and immunotherapies nature.com/articles/s41586-0…
45
This week's paper is by Daqi Li and Xiuxing Wang and team who show that tumour associated macrophages supply glioblastoma stem cells with lactate to promote their proliferation and induce KU70 lactylation to block cGAS-STING signalling and remodel the TME. nature.com/articles/s41556-0…
54
This week my recommended cancer metabolism paper is by Azusa Terasaki and Derick Okwan-Duodo and team who report that mitochondrial transfer from immune cells to cancer cells facilitates lymph node metastasis via the cGAS/STING immune evasion pathway. doi.org/10.1016/j.cmet.2025.…
39
This week's top paper is by Kimberley Huggler and Jason Cantor and team who show that hexokinase (HK) 2-dependence of cancer cells in HPLM is due to the subcellular distribution of HK1, with cytosolic HK supporting the Warburg effect. Great work! nature.com/articles/s42255-0…
45
This week's recommended read is by Jian Gu and LIng Lu and team who show that tumour-derived ammonia drives Treg-specific enrichment. Tregs detoxify ammonia via the urea cycle and spermine synthesis, boosting Tregs to drive resistance. Great work! doi.org/10.1016/j.cell.2025.…
52